Generation of recombinant canine interleukin-15 and evaluation of its effects on the proliferation and function of canine NK cells.
Soo-Hyeon Lee, Dong-Jun Shin, Sang-Ki Kim
Index: Vet. Immunol. Immunopathol. 165 , 1-13, (2015)
Full Text: HTML
Abstract
Interleukin-15 (IL-15) is a pleiotropic cytokine that plays a pivotal role in both innate and adaptive immunity. IL-15 is also a promising cytokine for treating cancer. Despite the growing importance of the clinical use of IL-15 for immunotherapy, no attempts have been made to generate a recombinant canine IL-15 (rcIL-15) and to examine its effects on the antitumor activities of immune effector cells in dogs. Here, we generated an rcIL-15 protein consisting of Asn-49-Ser-162 with a C-terminal His tag and examined its functions ex vivo in terms of the proliferation and antitumor effects on canine non-B, non-T, large granular natural killer (NK) cells. Non-B, non-T, large granular NK cells rapidly expanded in response to stimulation with rcIL-15 in the presence of IL-2, and a majority of the cells that selectively expanded over 21 days exhibited a CD3(-)CD5(-)CD4(-)CD8(+/-)CD21(-) phenotype. Purified rcIL-15 significantly enhanced the expansion rate of canine NK cells derived from peripheral blood mononuclear cells compared to human IL-15, or culture in the absence of IL-15 for 21 days (p<0.05). Purified rcIL-15 was superior at enhancing the effector function of NK cells compared to human IL-15. The cytotoxic activity against canine thyroid adenocarcinoma (CTAC) cells, interferon-γ production, and the mRNA expression levels of perforin and granzyme B of expanded NK cells cultured with rcIL-15 were significantly elevated compared to those cultured with human IL-15 or without IL-15 (p<0.05). Intravenous administration of rcIL-15 significantly increased the numbers of lymphocytes in the peripheral blood of dogs on days 6, 8, and 11 after injection compared to numbers before administration (p<0.05). The results of this study suggest that the rcIL-15 protein, consisting of Asn-49-Ser-162, enhanced the proliferation and antitumor effects of canine NK cells and promoted the generation of lymphocytes in dogs. Copyright © 2015 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
2015-04-01
[Angiogenesis 18(2) , 209-17, (2015)]
2015-01-01
[Drug Des. Devel. Ther. 9 , 1555-84, (2015)]
2015-04-17
[J. Biol. Chem. 290(16) , 10000-17, (2015)]
2015-02-17
[Proc. Natl. Acad. Sci. U. S. A. 112(7) , E747-56, (2015)]
2014-07-01
[Nucleic Acids Res. 42(13) , 8635-47, (2014)]